X-ray crystallography: assessment and validation of protein–small molecule complexes for drug discovery

Bibliography

• Hol WG. Protein crystallography and drug design. Arzneimittel-Forschung 1989;39:1016-18
   PubMed Web of Science ®Google Scholar
• Congreve M, Murray CW, Blundell TL. Structural biology and drug discovery. Drug Discov Today 2005;10:895-907
   PubMed Web of Science ®Google Scholar
• Zheng H, Chordia M, Cooper DR, CheckMyMetal (CMM): Validation of metal binding sites in protein structures. In preparation
   Google Scholar
• Chruszcz M, Borek D, Domagalski M, X-ray diffraction experiment - the last experiment in the structure elucidation process. Structural Genomics, Part C. San Diego: Elsevier Academic Press Inc 2009:23-40
   Google Scholar
• Chruszcz M, Wlodawer A, Minor W. Determination of protein structures - a series of fortunate events. Biophys J 2008;95:1-9
   PubMed Web of Science ®Google Scholar
• Hartshorn MJ, Murray CW, Cleasby A, Fragment-based lead discovery using X-ray crystallography. J Med Chem 2005;48:403-13
   PubMed Web of Science ®Google Scholar
• Jhoti H, Cleasby A, Verdonk M, Williams G. Fragment-based screening using X-ray crystallography and NMR spectroscopy. Curr Opin Chem Biol 2007;11:485-93
   PubMed Web of Science ®Google Scholar
• Scapin G. Structural biology and drug discovery. Curr Pharm Des 2006;12:2087-97
   PubMed Web of Science ®Google Scholar
• Wlodawer A, Minor W, Dauter Z, Jaskolski M. Protein crystallography for non-crystallographers, or how to get the best (but not more) from published macromolecular structures. FEBS J 2008;275:1-21
   PubMed Web of Science ®Google Scholar
• Carvalho AL, Trincao J, Romao MJ. X-ray crystallography in drug discovery. Methods Mol Biol 2009;572:31-56
   PubMedGoogle Scholar
• Walkinshaw MD. Protein targets for structure-based drug design. Med Res Rev 1992;12:317-72
   PubMed Web of Science ®Google Scholar
• Murray CW, Blundell TL. Structural biology in fragment-based drug design. Curr Opin Struct Biol 2010;20:497-507
   PubMed Web of Science ®Google Scholar
• Nienaber VL, Richardson PL, Klighofer V, Discovering novel ligands for macromolecules using X-ray crystallographic screening. Nat Biotechnol 2000;18:1105-8
   PubMed Web of Science ®Google Scholar
• Hajduk PJ, Greer J. A decade of fragment-based drug design: strategic advances and lessons learned. Nat Rev 2007;6:211-19
   Google Scholar
• Berman HM, Battistuz T, Bhat TN, The Protein Data Bank. Acta Crystallogr 2002;D58:899-907
   Google Scholar
• Zheng H, Chruszcz M, Lasota P, Data mining of metal ion environments present in protein structures. J Inorg Biochem 2008;102:1765-76
   PubMed Web of Science ®Google Scholar
• Allen FH. The cambridge structural database: a quarter of a million crystal structures and rising. Acta Crystallogr 2002;B58:380-8
   Web of Science ®Google Scholar
• Chruszcz M, Domagalski M, Osinski T, Unmet challenges of structural genomics. Curr Opin Struct Biol 2010;20:587-97
   PubMed Web of Science ®Google Scholar
• Hooft RW, Vriend G, Sander C, Abola EE. Errors in protein structures. Nature 1996;381:272
   PubMed Web of Science ®Google Scholar
• Laskowski RA, Macarthur MW, Moss DS, Thornton JM. Procheck - a Program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993;26:283-91
   Web of Science ®Google Scholar
• Ramachandran GN, Ramakrishnan C, Sasisekharan V. Stereochemistry of polypeptide chain configurations. J Mol Biol 1963;7:95-9
   PubMed Web of Science ®Google Scholar
• Adams PD, Afonine PV, Bunkoczi G, PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr 2010;66:213-21
   PubMed Web of Science ®Google Scholar
• Chen VB, Arendall WB 3rd, Headd JJ, MolProbity: All-atom structure validation for macromolecular crystallography. Acta Crystallogr 2010;D66:12-21
   Web of Science ®Google Scholar
• Davis IW, Leaver-Fay A, Chen VB, MolProbity: All-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 2007;35:W375-83
   PubMed Web of Science ®Google Scholar
• Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr 2010;D66:486-501
   Google Scholar
• Berjanskii M, Liang Y, Zhou J, PROSESS: a protein structure evaluation suite and server. Nucleic Acids Res 2010;38 Suppl:W633-40
   Google Scholar
• Altschul SF, Gish W, Miller W, Basic local alignment search tool. J Mol Biol 1990;215:403-10
   PubMed Web of Science ®Google Scholar
• Minor W, Cymborowski M, Otwinowski Z, Chruszcz M. HKL-3000: the integration of data reduction and structure solution--from diffraction images to an initial model in minutes. Acta Crystallogr 2006;D62:859-66
   Google Scholar
• Cymborowski M, Klimecka M, Chruszcz M, To automate or not to automate: this is the question. J Struct Funct Genomics 2010;11:211-21
   PubMedGoogle Scholar
• Miller G. Scientific publishing. A scientist's nightmare: software problem leads to five retractions. Science 2006;314:1856-7
   PubMed Web of Science ®Google Scholar
• Nicholls A, McGaughey GB, Sheridan RP, Molecular shape and medicinal chemistry: a perspective. J Med Chem 2010;53:3862-86
   PubMed Web of Science ®Google Scholar
• Malde AK, Mark AE. Challenges in the determination of the binding modes of non-standard ligands in X-ray crystal complexes. J Comput Aided Mol Des 2011;25:1-12
   Google Scholar
• Kleywegt GJ. On vital aid: the why, what and how of validation. Acta Crystallogr 2009;D65:134-9
   Google Scholar
• Kleywegt GJ, Henrick K, Dodson EJ, van Aalten DM. Pound-wise but penny-foolish: How well do micromolecules fare in macromolecular refinement? Structure 2003;11:1051-9
   PubMed Web of Science ®Google Scholar
• Andrejasic M, Praaenikar J, Turk D. PURY: a database of geometric restraints of hetero compounds for refinement in complexes with macromolecular structures. Acta Crystallogr 2008;D64:1093-109
   Google Scholar
• Kleywegt GJ. Crystallographic refinement of ligand complexes. Acta Crystallogr 2007;D63:94-100
   Google Scholar
• Evans PR. An introduction to stereochemical restraints. Acta Crystallogr 2007;D63:58-61
   Google Scholar
• Schuttelkopf AW, van Aalten DM. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr 2004;D60:1355-63
   Web of Science ®Google Scholar
• Moriarty NW, Grosse-Kunstleve RW, Adams PD. electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation. Acta crystallogr 2009;65:1074-80
   PubMed Web of Science ®Google Scholar
• Gront D. In preparation
   Google Scholar
• Kleywegt GJ, Harris MR. ValLigURL: a server for ligand-structure comparison and validation. Acta crystallogr 2007;63:935-8
   Web of Science ®Google Scholar
• Adams PD, Gopal K, Grosse-Kunstleve RW, Recent developments in the PHENIX software for automated crystallographic structure determination. J Synchrotron Radiat 2004;11:53-5
   PubMed Web of Science ®Google Scholar
• Grabowski M, Chruszcz M, Zimmerman MD, Benefits of structural genomics for drug discovery research. Infect Disord Drug Targets 2009;9:459-74
   PubMedGoogle Scholar
• Choi J, Chon JK, Kim S, Shin W. Conformational flexibility in mammalian 15S-lipoxygenase: Reinterpretation of the crystallographic data. Proteins 2008;70:1023-32
   PubMed Web of Science ®Google Scholar
• Saikatendu KS, Zhang X, Kinch L, Structure of a conserved hypothetical protein SA1388 from S. aureus reveals a capped hexameric toroid with two PII domain lids and a dinuclear metal center. BMC Struct Biol 2006;6:27
   PubMedGoogle Scholar
• Poon BK, Grosse-Kunstleve RW, Zwart PH, Sauter NK. Detection and correction of underassigned rotational symmetry prior to structure deposition. Acta crystallogr 2010;D66:503-13
   Google Scholar
• Joosten RP, Vriend G. PDB improvement starts with data deposition. Science 2007;317:195-6
   PubMed Web of Science ®Google Scholar
• Joosten RP, Womack T, Vriend G, Bricogne G. Re-refinement from deposited X-ray data can deliver improved models for most PDB entries. Acta Crystallogr 2009;D65:176-85
   Google Scholar
• Kim YJ, Doyle ML. Structural mass spectrometry in protein therapeutics discovery. Anal Chem 2010;82:7083-9
   PubMed Web of Science ®Google Scholar
• Gibbs AC, Abad MC, Zhang X, Electron density guided fragment-based lead discovery of ketohexokinase inhibitors. J Med Chem 2010;53:7979-91
   PubMed Web of Science ®Google Scholar
• Derewenda ZS, Vekilov PG. Entropy and surface engineering in protein crystallization. Acta Crystallogr 2006;D62:116-24
   Google Scholar
• Dong A, Xu X, Edwards AM, In situ proteolysis for protein crystallization and structure determination. Nat Methods 2007;4:1019-21
   PubMed Web of Science ®Google Scholar
• Koide S. Engineering of recombinant crystallization chaperones. Curr Opin Struct Biol 2009;19:449-57
   PubMed Web of Science ®Google Scholar
• McPherson A, Cudney B. Searching for silver bullets: an alternative strategy for crystallizing macromolecules. J Struct Biol 2006;156:387-406
   PubMed Web of Science ®Google Scholar
• Joachimiak A. High-throughput crystallography for structural genomics. Curr Opin Struct Biol 2009;19:573-84
   PubMed Web of Science ®Google Scholar
• Broennimann C, Eikenberry EF, Henrich B, The PILATUS 1M detector. J Synchrotron Radiat 2006;13:120-30
   PubMed Web of Science ®Google Scholar
• Gruner SM, Tate MW, Eikenberry EF. Charge-coupled device area x-ray detectors. Rev Sci Instruments 2002;73:2815-42
   Web of Science ®Google Scholar
• Kraft P, Bergamaschi A, Broennimann C, Performance of single-photon-counting PILATUS detector modules. J Synchrotron Radiat 2009;16:368-75
   PubMed Web of Science ®Google Scholar
• Sakabe K, Sasaki K, Watanabe N, Large-format imaging plate and Weissenberg camera for accurate protein crystallographic data collection using synchrotron radiation. J Synchrotron Radiat 1997;4:136-46
   PubMed Web of Science ®Google Scholar
• The CCP4 suite: programs for protein crystallography. Acta Crystallogr 1994;D50:760-3
   Google Scholar
• Warren GL, Andrews CW, Capelli AM, A critical assessment of docking programs and scoring functions. J Med Chem 2006;49:5912-31
   PubMed Web of Science ®Google Scholar
• Nam KH, Sung MW, Hwang KY. Structural insights into the substrate recognition properties of beta-glucosidase. Biochem Biophys Res Commun 2010;391:1131-5
   PubMed Web of Science ®Google Scholar
• Myler PJ, Stacy R, Stewart L, The Seattle Structural Genomics Center for Infectious Disease (SSGCID). Infect Disord Drug Targets 2009;9:493-506
   PubMedGoogle Scholar
• Anderson WF. Structural genomics and drug discovery for infectious diseases. Infect Disord Drug Targets 2009;9:507-17
   PubMedGoogle Scholar
• Minor W, Steczko J, Stec B, Crystal structure of soybean lipoxygenase L-1 at 1.4 A resolution. Biochemistry 1996;35:10687-701
   PubMed Web of Science ®Google Scholar
• Joosten RP, Salzemann J, Bloch V, PDB_REDO: automated re-refinement of X-ray structure models in the PDB. J Appl Crystallogr 2009;42:376-84
   PubMed Web of Science ®Google Scholar
• Furet P, Meyer T, Strauss A, Structure-based design and protein X-ray analysis of a protein kinase inhibitor. Bioorg Med Chem Lett 2002;12:221-4
   PubMed Web of Science ®Google Scholar
• Kurumbail RG, Stevens AM, Gierse JK, Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 1996;384:644-8
   PubMed Web of Science ®Google Scholar